FDA Inspection 1077742 — The Nebraska Medical Center

The Nebraska Medical Center — FEI 3000210077

The FDA completed an inspection of The Nebraska Medical Center on December 13, 2018 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 13, 2018
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Omaha, NE (United States)